1992PubMedRequires access

[Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion].

Takahiro Mori, Yasushi Iwasaki, K Takahashi, Tohru Takahashi

Open publisher page 3 citations

Abstract

The adequate flow volume and dose of 5-FU with the blood flow of proper hepatic artery in continuous hepatic infusion was investigated using young pig. The arterial blood flow of proper hepatic artery of pig per minute was 41.2 ml on average. 5-FU concentration was calculated in hepatic vein and peripheral vein during arterial infusion. When the speed and volume were put at 5 mg/kg/day and 5 ml/day, no 5-FU was recognized either in hepatic vein or peripheral vein. Also, at this low dose and flow volume, F-dUMP was recognized in liver tissue, and the thymidylate synthetase inhibition rate was 10-20%. From the standpoint that 5-FU is a time dependent drug effective for tumor cells only in the S-phase, continuous infusion of 5-FU will be much more effective than one-shot administration so as to prolong the presence of 5-FU even when the TS inhibition rate is low.

About this research paper

What this paper is about

The adequate flow volume and dose of 5-FU with the blood flow of proper hepatic artery in continuous hepatic infusion was investigated using young pig. The arterial blood flow of proper hepatic artery of pig per minute was 41.2 ml on average. 5-FU concentration was calculated in hepatic vein and peripheral vein during arterial infusion. When the speed and volume were put at 5 mg/kg/day and 5 ml/day, no 5-FU was recognized either in hepatic vein or peripheral vein. Also, at this low dose and flow volume, F-dUMP was recognized in liver tissue, and the thymidylate synthetase inhibition rate was 10-20%. From the standpoint that 5-FU is a time dependent drug effective for tumor cells only in the S-phase, continuous infusion of 5-FU will be much more effective than one-shot administration so as to prolong the presence of 5-FU even when the TS inhibition rate is low.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The adequate flow volume and dose of 5-FU with the blood flow of proper hepatic artery in continuous hepatic infusion was investigated using young pig. The arterial blood flow of proper hepatic artery of pig per minute was 41.2 ml on average. 5-FU concentration was calculated in hepatic vein and peripheral vein during arterial infusion. When the speed and volume were put at 5 mg/kg/day and 5 ml/day, no 5-FU was recognized either in hepatic vein or peripheral vein. Also, at this low dose and flow volume, F-dUMP was recognized in liver tissue, and the thymidylate synthetase inhibition rate was 10-20%. From the standpoint that 5-FU is a time dependent drug effective for tumor cells only in the S-phase, continuous infusion of 5-FU will be much more effective than one-shot administration so as to prolong the presence of 5-FU even when the TS inhibition rate is low.

Key concepts: Artery, Vein, Medicine, Hepatic arterial infusion, Blood flow, Continuous infusion, Peripheral, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
[Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion]. — Research Paper | ScholarLens